Document is current
Any future updates will be listed below
-
Authors
Noort, F. van den
Borg, F. ter
Guitink, A.
Faber, J.
Wolterink, J. M.
-
Funding
Funding for this research was provided by:
Pioneers in Health Care Innovation Fund, University of Twente (a Tempo study, a Tempo study, a Tempo study)
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 6 November 2024
First Online: 13 December 2024
Declarations
:
: The authors declare no competing interests.
: All the patients provided written informed consent for the use of EUS and pathology data.
: The medical ethics committee of the Isala Clinics (Zwolle, Netherlands) judged that the study was not subject to the Medical Research Involving Human Subjects Act (WMO), because there was no extra burden to the patient with regards to standard clinical care.
: In the methods we state the following: The medical ethics committee of the Isala Clinics (Zwolle, the Netherlands) judged that the study was not subject to the Medical Research Involving Human Subjects Act (WMO), because there was no extra burden to the patient with regards to standard clinical care.
: This means that the medical ethics commitee checked the study but judged that no ethical approval was needed, only informed consent of the patients to use their data in the study. This was decided since there is no extra burden to the patients. The data was already collected as part of their path to correct polyp diagnosis.
Free to read: This content has been made available to all.
